PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Gonzalez-Rellan, M.J.* ; Fondevila, M.F.* ; Fernandez, U.* ; Rodriguez, A.* ; Varela-Rey, M.* ; Veyrat-Durebex, C.* ; Seoane, S.* ; Bernardo, G.* ; Lopitz-Otsoa, F.* ; Fernández-Ramos, D.* ; Bilbao, J.* ; Iglesias, C.* ; Novoa, E.* ; Ameneiro, C.* ; Senra, A.* ; Beiroa, D.* ; Cuñarro, J.* ; DP Chantada-Vazquez, M.* ; Garcia-Vence, M.* ; Bravo, S.B.* ; Da Silva Lima, N.* ; Porteiro, B.* ; Carneiro, C.* ; Vidal, A.* ; Tovar, S.* ; Müller, T.D. ; Ferno, J.* ; Guallar, D.* ; Fidalgo, M.* ; Sabio, G.* ; Herzig, S. ; Yang, W.H.* ; Cho, J.W.* ; Martínez-Chantar, M.L.* ; Perez-Fernandez, R.* ; López, M.* ; Dieguez, C.* ; Mato, J.M.* ; Millet, O.* ; Coppari, R.* ; Woodhoo, A.* ; Fruhbeck, G.* ; Nogueiras, R.*

O-GlcNAcylated p53 in the liver modulates hepatic glucose production.

Nat. Commun. 12:5068 (2021)
Verlagsversion DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
p53 regulates several signaling pathways to maintain the metabolic homeostasis of cells and modulates the cellular response to stress. Deficiency or excess of nutrients causes cellular metabolic stress, and we hypothesized that p53 could be linked to glucose maintenance. We show here that upon starvation hepatic p53 is stabilized by O-GlcNAcylation and plays an essential role in the physiological regulation of glucose homeostasis. More specifically, p53 binds to PCK1 promoter and regulates its transcriptional activation, thereby controlling hepatic glucose production. Mice lacking p53 in the liver show a reduced gluconeogenic response during calorie restriction. Glucagon, adrenaline and glucocorticoids augment protein levels of p53, and administration of these hormones to p53 deficient human hepatocytes and to liver-specific p53 deficient mice fails to increase glucose levels. Moreover, insulin decreases p53 levels, and over-expression of p53 impairs insulin sensitivity. Finally, protein levels of p53, as well as genes responsible of O-GlcNAcylation are elevated in the liver of type 2 diabetic patients and positively correlate with glucose and HOMA-IR. Overall these results indicate that the O-GlcNAcylation of p53 plays an unsuspected key role regulating in vivo glucose homeostasis.
Impact Factor
Scopus SNIP
Scopus
Cited By
Altmetric
14.919
3.055
22
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Phosphoenolpyruvate Carboxykinase; Insulin Sensitivity; Up-regulation; Metabolism; Activation; Gene; Gluconeogenesis; Transcription; Inflammation; Transferase
Sprache englisch
Veröffentlichungsjahr 2021
HGF-Berichtsjahr 2021
ISSN (print) / ISBN 2041-1723
e-ISSN 2041-1723
Zeitschrift Nature Communications
Quellenangaben Band: 12, Heft: 1, Seiten: , Artikelnummer: 5068 Supplement: ,
Verlag Nature Publishing Group
Verlagsort London
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Diabetes and Obesity (IDO)
Institute of Diabetes and Cancer (IDC)
POF Topic(s) 90000 - German Center for Diabetes Research
Forschungsfeld(er) Helmholtz Diabetes Center
PSP-Element(e) G-501900-221
G-501900-251
Förderungen Programa Retos
Proyectos Investigacion en Salud
Fundacion BBVA
Xunta de Galicia
Fundacion Atresmedia
Gilead Sciences International Research Scholars Program in Liver Disease
FEDER funds
ERC Consolidator Grant
European Community's H2020 Framework Program under the following grant: ERC Synergy Grant
German Research Foundation DFG
European Foundation for the Study of Diabetes
Basque Department of Industry, Tourism and Trade
National Research Foundation of Korea Grant, Ministry of Science, ICT and Future Planning
Helse Vest RHF
Western Norway Regional Health Authority
FEDER/Ministerio de Ciencia, Innovacion y Universidades-Agencia Estatal de Investigacion
DOI 10.1038/s41467-021-25390-0
WOS ID WOS:000687171500012
Scopus ID 85113240810
PubMed ID 34417460
Erfassungsdatum 2021-09-22
[➜Korrektur melden]